Parexel has revealed that it is expanding its clinical trial services to include logistics for the global supply of clinical trial supply materials. The company's Clinical Logistics Services segment now offers the centralised coordination of clinical study supplies, laboratory services, and ancillary supplies, as well as distribution and warehousing capabilities to handle and transport clinical study supplies to locations worldwide, and technology systems to track shipments and inventory levels. These services are supported by enabling technology solutions, including Interactive Voice and Web Response Systems (IVRS/IWRS), and systems for product tracking, laboratory operations management, and warehouse management, said Parexel. The contract research organisation (CRO) pointed out that one of the most frequently reported causes of study delays is the lack of available study drug caused by late or incomplete arrival of clinical supplies. "These problems can result in costly delays and cause critical milestones to be missed," said Mark Goldberg, president of Clinical Research Services and Perceptive Informatics. "With growing study complexity and increasing globalisation of clinical research, biopharmaceutical companies need to fully integrate clinical logistics into study design and execution." As such Parexel said it can incorporate logistical planning into the clinical study process from the beginning, "so that the supply system meshes seamlessly with study requirements and timelines". Meanwhile, Sentry Logistic Solutions has announced that it is now offering temperature-controlled labelling, packaging and kitting services for the biopharma industry. "Custom Finishing Services are an integral part of the pharmaceutical supply chain," said Jennifer Marcum, Sentry's CEO, adding that the ultimate goal of these new services is to "manage risk and eliminate unnecessary supply chain costs while maintaining or exceeding service levels." Citing Center for Drug Evaluation and Research (CDER) statistics, five of the top ten reasons for pharmaceutical recalls include miscellaneous cGMP deviations, impurities in or degradation of products, lack of product stability, labelling errors on declared strength, and incorrect products in cartons or packages, costing the industry billions of dollars a year. Sentry said because it offers a cGMP, validated storage facility and inventory management system, "good manufacturing practices are ensured, expiration dates are managed and tracked, product integrity is maintained, and labelling or re-labelling can be accurately executed to prevent costly errors". "Sentry's On-Demand finishing services can be executed within validated temperature environments to reduce or eliminate time-out-of-temperature. Benefits of this program include decreased product risk, improved quality control, and enhanced product integrity throughout the supply chain", the firm said. In other news, IT services firm TechTeam Global has announced the creation of a Global Pharmaceutical Center of Excellence, to ensure that its IT outsourcing services are aligned with the "unique needs" of the pharmaceutical industry. "The pharmaceutical industry has unique and quickly evolving needs. With TechTeam's global support structure, industry focus and scalable model, we offer a flexible and agile approach to meet those needs", said said Joanna Gutkowski, who will lead TechTeam's Pharma Center of Excellence. "We have provided support to customers in the pharmaceutical industry for nearly a decade. The decision to create a Pharma Center of Excellence reflects our commitment to the pharmaceutical industry and to meeting its growing needs," said Gary Cotshott, president and CEO of TechTeam. "In the future, we foresee the focus of the Center of Excellence broadening to cover the full life sciences industry".